全文获取类型
收费全文 | 515篇 |
免费 | 27篇 |
国内免费 | 1篇 |
专业分类
财政金融 | 22篇 |
工业经济 | 17篇 |
计划管理 | 128篇 |
经济学 | 232篇 |
综合类 | 40篇 |
运输经济 | 3篇 |
旅游经济 | 8篇 |
贸易经济 | 30篇 |
农业经济 | 42篇 |
经济概况 | 21篇 |
出版年
2023年 | 11篇 |
2022年 | 5篇 |
2021年 | 14篇 |
2020年 | 38篇 |
2019年 | 22篇 |
2018年 | 25篇 |
2017年 | 37篇 |
2016年 | 22篇 |
2015年 | 25篇 |
2014年 | 33篇 |
2013年 | 124篇 |
2012年 | 23篇 |
2011年 | 43篇 |
2010年 | 34篇 |
2009年 | 12篇 |
2008年 | 19篇 |
2007年 | 7篇 |
2006年 | 11篇 |
2005年 | 6篇 |
2004年 | 4篇 |
2003年 | 8篇 |
2002年 | 2篇 |
2001年 | 8篇 |
2000年 | 3篇 |
1999年 | 5篇 |
1996年 | 1篇 |
1990年 | 1篇 |
排序方式: 共有543条查询结果,搜索用时 15 毫秒
481.
482.
Pamela Vo Wei Gao Miriam L. Zichlin Eleanore Fuqua Ela Fadli Marta Aguirre Vazquez 《Journal of medical economics》2013,16(9):953-959
AbstractAims: This retrospective chart review examined the six-month migraine-related healthcare resource use (HRU) among European patients who had ≥4 migraine days per month and previously failed at least two prophylactic migraine treatments.Methods: Neurologists, headache specialists, and pain specialists in France, Germany, Italy, and Spain who treated ≥10 patients with migraine in 2017 were recruited (April–June 2018) to extract anonymized patient-level data. Eligible physicians randomly selected charts of up to five adult patients with clinically-confirmed migraine, ≥4 migraine days in the month prior to the index date, and had previously failed at least two prophylactic migraine treatments. Treatment failure was defined as discontinuation due to lack of efficacy and/or tolerability. Demographic and disease characteristics as of the index date, and migraine-related HRU incurred during the 6-month study period, were recorded.Results: A total of 104 physicians contributed 168 charts for patients (63% female). On average, patients were 38?years old and failed 2.3 prophylactic treatments as of the index date. During the study period, 83% of patients had ≥1 outpatient visit for migraine in the physician’s office, and 27% went to the ER/A&E. Approximately 5% of patients were hospitalized for migraine, with an average of one hospitalization and an average length of stay of 3 days. Approximately 39% of patients had ≥1 blood test, 22% had ≥1 magnetic resonance imaging, 17% had ≥1 electroencephalogram, and 13% had ≥1 computerized tomography scan. Visits to other healthcare providers were common.Limitations: This study is subject to the limitations of chart review studies, such as errors in data entry.Conclusions: Across four European countries, the HRU burden of migraine among patients who previously failed at least two prophylactic treatments was high, indicating a need for more effective prophylactic treatments to appropriately manage migraine and reduce the HRU burden attributable to this common disorder. 相似文献
483.
484.
《Journal of medical economics》2013,16(3):449-470
AbstractObjective: To determine factors associated with the achievement of optimal lipid values (OLVs) and subsequent impact on clinical and economic outcomes.Methods: An observational managed care database analysis was conducted among treatment-naïve adults with elevated cardiovascular (CV) risk, ≥12 months follow-up and full lipid panel from the 1st January 2002 to the 28th February 2005. Achievement of guideline-based levels for low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and triglycerides was evaluated via laboratory data. Annual CV-attributable resource utilisation was assessed via medical and pharmacy claims data. Clinical and economic outcomes associated with the achievement of OLVs were assessed using multivariate regression.Results: A total of 52,778 patients were followed for a mean (standard deviation) of 27 (10) months with 13% achieving combined OLVs at baseline and 23% after 4 years. Of patients, 69% did not initiate lipid-modifying medication. The achievement of combined OLVs reduced the risk of CV event (odds ratio = 0.86; 95% confidence interval 0.78–0.95), resource utilisation (inpatient visits: 3.36 vs. 4.41 per 100 patient years, p<0.0001; emergency department visits: 1.1 vs. 2.4 per 100 patient years, p<0.05) and costs: $703 vs. $903 per patient year, p<0.0001.Conclusions: Simultaneous achievement of OLVs was rare in this patient population. Physicians should be encouraged to manage multiple risk factors aggressively to improve clinical and economic outcomes associated with CV disease. 相似文献
485.
486.
2011年全国传染病医院资产规模扩张速度快,有持续发展能力。应加强成本核算,控制成本支出,加强资产管理,提高资产利用率,提升服务质量,增加业务收入,提高工作效率,加快转型发展。 相似文献
487.
自然地质环境与人类健康研究 总被引:1,自引:0,他引:1
本文对自然地质环境和人类健康的关系进行了初步探讨,揭示人类的身体健康与自然地质环境密切相关。正如《黄帝内经 》中所说“人与天地相应”,指出了人体与自然地质环境相互依存又相互制约的关系。当周围环境中缺少了人体必须的物质成份,人就会罹患生物地球化学性疾病。有利于人类健康的自然地质环境可使人健康长寿,不利于人类健康的自然地质环境则导致各种传染和非传染性疾病。 相似文献
488.
文章分析了我国疾病预防控制体系建设的历程,提出了疾病预防控制文化的内涵,分析了疾病预防控制的意义,研究了欠发达地区疾病预防控制文化建设存在的不足和问题,并提出了加强欠发达地区疾病预防控制文化建设的思路和营销策略。 相似文献
489.
Livestock Disease Indemnity Design When Moral Hazard Is Followed by Adverse Selection 总被引:1,自引:0,他引:1
Benjamin M. Gramig Richard D. Horan Christopher A. Wolf 《American journal of agricultural economics》2009,91(3):627-641
Averting or limiting the outbreak of infectious disease in domestic livestock herds is an economic and potential human health issue that involves the government and individual livestock producers. Producers have private information about preventive biosecurity measures they adopt on their farms prior to outbreak ( ex ante moral hazard), and following outbreak they possess private information about whether or not their herd is infected ( ex post adverse selection). We investigate how indemnity payments can be designed to provide incentives to producers to invest in biosecurity and report infection to the government in the presence of asymmetric information. We compare the relative magnitude of the first- and second-best levels of biosecurity investment and indemnity payments to demonstrate the tradeoff between risk sharing and efficiency, and we discuss the implications for status quo U.S. policy. 相似文献
490.
《Journal of medical economics》2013,16(4):591-598
Objective:Treatment in the hospital setting accounts for the largest portion of healthcare costs for COPD, but there is little information about components of hospital care that contribute most to these costs. The authors determined the costs and characteristics of COPD-related hospital-based healthcare in a Medicare population.MethodsUsing administrative data from 602 hospitals, 2008 costs of COPD-related care among Medicare beneficiaries age ≥65 years were calculated for emergency department (ED) visits, simple inpatient admissions and complex admissions (categorized as intubation/no intensive care, intensive care/no intubation, and intensive care/intubation) in a cross-sectional study. Rates of death at discharge and trends in costs, length of stay and readmission rates from 2005 to 2008 also were examined.Main results:There were 45,421 eligible healthcare encounters in 2008. Mean costs were $679 (SD, $399) for ED visits (n = 10,322), $7,544 ($8,049) for simple inpatient admissions (n = 25,560), and $21,098 ($46,160) for complex admissions (n = 2,441). Intensive care/intubation admissions (n = 460) had the highest costs ($45,607, SD $94,794) and greatest length of stay (16.3 days, SD 13.7); intubation/no ICU admissions had the highest inpatient mortality (42.1%). In 2008, 15.4% of patients with a COPD-related ED visit had a repeat ED visit and 15.5–16.5% of those with a COPD-related admission had a readmission within 60 days. From 2005 to 2008, costs of admissions involving intubation increased 10.4–23.5%. Study limitations include the absence of objective clinical data, including spirometry and smoking history, to validate administrative data and permit identification of disease severity.Conclusions:In this Medicare population, COPD exacerbations and related inpatient and emergency department care represented a substantial cost burden. Admissions involving intubation were associated with the highest costs, lengths of stay and inpatient mortality. This population needs to be managed and treated adequately in order to prevent these severe events. 相似文献